Related Articles
The enhanced transcriptional activity of the V-val subtype of Epstein-Barr virus nuclear antigen 1 in epithelial cell lines
The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal
Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter
Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism
Lentivirus‑mediated RNA interference targeting EBNA1 gene inhibits the growth of GT‑38 cells in vitro and in vivo